AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2534978123
Affiliations:
4
Authors:
13
Go to article
Institutions Authors Share
Shanghai University of Traditional Chinese Medicine (SHUTCM), China
10.000000
10.000000
 0.77
Shanghai Shuguang Hospital, China
2.000000
 0.15
First Affiliated Hospital, AHMU, China
1.000000
 0.08
Interested in Oncology and Carcinogenesis?